Table 5.
Modified Framingham Stroke Profile
| Risk factor | Points |
|---|---|
| Age | |
| 54−56 y | 0 |
| 57−59 y | 1 |
| 60−62 y | 2 |
| 63−65 y | 3 |
| 66−68 y | 4 |
| 69−71 y | 5 |
| 72−74 y | 6 |
| 75−77 y | 7 |
| 78−80 y | 8 |
| 81−83 y | 9 |
| 84−86 y | 10 |
| Systolic blood pressure | |
| 95−105 mm Hg | 0 |
| 106−116 mm Hg | 1 |
| 117−126 mm Hg | 2 |
| 127−137 mm Hg | 3 |
| 138−148 mm Hg | 4 |
| 149−159 mm Hg | 5 |
| 160−170 mm Hg | 6 |
| 171−181 mm Hg | 7 |
| 182−191 mm Hg | 8 |
| 192−202 mm Hg | 9 |
| 203−213 mm Hg | 10 |
| Treated systolic pressure | 2 |
| Diabetes mellitus | 2 |
| Cigarette smoking | 3 |
| CHD | 3 |
| Atrial fibrillation | 4 |
| Left ventricular hypertrophy on EKG | 6 |
Data from Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.